NCT06333327Recruiting

Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter

Name: Clinical Trial NCT06333327
Creator: Universitair Ziekenhuis Brussel
Keywords: Atrial Fibrillation, Pulmonary vein isolation with the multielectrode radiofrequency balloon catheter, device, clinical trial, Belgium

Multielectrode Radiofrequency Balloon for Atrial Fibrillation Catheter Ablation: A Multicenter Real-World Experience

Universitair Ziekenhuis BrusselClinicalTrials.govdeviceDevice trial

Verified

Study focus

Disease/Condition: Atrial Fibrillation
Drug/Device/Intervention: Pulmonary vein isolation with the multielectrode radiofrequency balloon catheter
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: Universitair Ziekenhuis Brussel
Location: Brussels, Belgium

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2021
End date: Dec 01, 2030
Enrollment: 2000 participants

Primary outcome

Atrial arrhythmia recurrence after ablation,Procedural safety

Summary

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) Heliostar (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.

ICD-10 classifications

Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06333327
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06333327 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitair Ziekenhuis Brussel and is currently Recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 2000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.